Skip to content

Home hemodialysis

Why home hemodialysis (Home HD)?

Home HD is a home-based and therefore a flexible treatment option. Patients, dialyzing at home can, within the prescribed treatment plan, vary the frequency of dialysis treatment and therefore can benefit from improvement in aspects of quality of life and medical outcomes as described in more detail in the following.1,2

In the following we answer some of your questions, including

  • How can Fresenius Medical Care support outcomes for my HHD patients?
  • Which training solutions does Fresenius Medical Care offer for patients and HCPs?
  • How does Fresenius Medical Care enable reliable technical support?

Our Products

nxstage
NxStage System One
  • Setup and system installation, with an option of two dialysate sources, either prefabricated bags or PureFlow SL, that produces dialysate directly at the point-of-care
  • Convenient handling with a unique cartridge system and an intuitive interface
  • Portability due to a small and compact size / design
5008S CorDiax
5008S CorDiax*
  • Individually adjustable with a variety of therapy
    prescriptions which can be adapted to patients’ evolving medical and lifestyle needs

  • Performance you trust and know from our in-center devices, available for your patients at home.

  • A way to save time and reduce steps due to automatic disinfection of the AquaC UNO H water treatment system, which requires little to no disinfection by the patient

* The 5008S CorDiax consists of the product 5008S and a software version greater than 4.50. All features described are offered with the 5008S CorDiax.

Discover more about our NxStage System One and 5008S CorDiax
NxStage System One - female patient

The NxStage System One home hemodialysis machine offers the convenience of portability for treatment in the comfort of a patient’s home.

man sitting next to 5008S CorDiax

Performance you know and trust in-center – the 5008S CorDiax is also available at home, offering different benefits for patients.

lifestyle women garden

How home dialysis can improve patients' lives

Fresenius Medical Care offers flexible home hemodialysis therapy options that allow patients to dialyze during the day or night. When dialyzing at night, patients are able to sleep during treatment, allowing them to spend their day their way.

Take part in making patients’ lives easier

As a healthcare professional, together with your patients, you can choose a system that works best for their lifestyles and individual requirements.

Why patients can benefit from home hemodialysis

Most people who perform home hemodialysis may extend their treatment time per week, if required, to improve their treatment outcomes. This can be done by performing their therapy more frequently at four to seven days a week and/or performing their treatment overnight.

More flexibility & control

Home hemodialysis gives your patient the freedom to spend more time doing the things they like to do. Whether their passion is fishing or traveling, home hemodialysis has the potential to give them the flexibility to better engage in employment and social life! 7

More frequent hemodialysis is associated with

heart CVD

Less stress on the heart 3,4

blood cell

Better blood pressure control with fewer medications 4,5

Apple

Less restrictive diet 2,6

battery

Possibly improved energy levels 8

time

Quicker recovery time after treatment 9

lifestyle

Flexibility to take control of their life 7,10

Treatment options

At home you can adjust frequency and duration of dialysis for your patients.

Shared decision making between patient and physician supports finding the right therapy fit - depending on patients’ therapy needs and lifestyle.

More frequent and / or long duration hemodialysis has been shown to improve clinical outcomes.

Facts about dialysis

Nocturnal home hemodialysis

Home nocturnal hemodialysis is performed overnight while the patient and care partner are sleeping. It can be a slower and longer treatment that more closely resembles healthy kidney function, which may be gentler on the heart (e.g. reduction of left ventricular mass, hypertension and interdialytic hypotension) compared to standard thrice-weekly dialysis. 5,11

Nocturnal hemodialysis has been shown to improve phosphorus control, which could result in a more liberal diet.11

Moreover, extended weekly dialysis time may improve ß2m clearance compared to thrice-weekly hemodialysis.12

In addition, patients are able to spend more time during the day for work, childcare and travel. Nocturnal HHD may also relieve scheduling concerns for care partners.

Let us help you get started and grow your home hemodialysis program.

Training – Advanced treatment, simple setup

Getting started with HHD

With HHD, a highly effective treatment is moving in, that today can be set up and run conveniently in the patients’ homes. From training videos for caregivers and patients to home setup by a team of specialists, we get it right from the start.

Support and monitor – In touch with every treatment

HHD monitoring and support

Once HHD therapy is running, we offer a range of services to support you in conveniently reducing your workload and reducing treatment interruptions.

DISCLAIMER

Not all products and services are cleared or available for sale in all EU countries. Check your country web site for details. 

Related content
NxStage System One - female patient

The NxStage System One home hemodialysis machine offers the convenience of portability for treatment in the comfort of a patient’s home.

man sitting next to 5008S CorDiax

Performance you know and trust in-center – the 5008S CorDiax is also available at home, offering different benefits for patients.

1 Miller BW et al. Blood Purif 2018; 45(1-3):224-229

2 Tennankore KK et al. Nat Rev Nephrol 2012; 8(9):515-522

3 McCullough PA et al. Am J Kidney Dis 2016; 68(5):5–14

4 Susantitaphong P et al. Am J Kidney Dis 2012; 59(5):689–699

5 Kotanko P Hemodial Int 2015; 19(3):386-401

6 Watanabe Y Hemodial Int 2014; 18(1):32-38

7 Walker RC et al. Am J Kidney Dis 2015; 65(3):451-463

8 Finkelstein FO et al. Kidney Int 2012; 82(5):561-569

9 Jaber BL et al. Am J Kidney Dis 2010; 56(3):531-539 

10 Walker RC et al. Clin Outcomes Res 2017; 9:149-161

11 Culleton BF et al. JAMA 2007; 298(11):1291-1299

12 Portales-Castillo I et al. Kidney360 2020; 1(12):1447-1455